Opinion

RFK Jr. wants to ban kratom and its compounds. The consequences could be deadly. | Opinion

Either let 7-OH fall into the hands of cartels or regulate it to reduce harm. America doesn't need another fentanyl crisis.
Fierce Pharma

FDA greenlights Stealth Bio’s injection as 1st treatment for Barth syndrome

Stealth’s injection, known as elamipretide, will be sold as Forzinity for the treatment of Barth syndrome, an X-linked ...

“Unacceptable”: Prominent U.S. Senators Demand FDA Provide Names of Troubled Foreign Drugmakers Skirting Import Bans

Fla., and Kirsten Gillibrand, D-N.Y., said they had “urgent concerns” about the agency’s oversight of foreign drugmakers and ...

ACIP’s moves on vaccines

OMUFA MAY HITCH A RIDE — The House GOP stopgap funding bill includes a reauthorization of the FDA’s Over-the-Counter ...

RFK Jr.’s vaccine panel makes a controversial change to the childhood vaccine schedule

The panel voted to recommend against the combined measles, mumps, rubella and chickenpox vaccine for young children. It ...

The FDA Is Trying To Make Corporate Free Speech Situational

Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human ...

FDA targets drug marketing, advertising with slew of warning letters

The FDA cracks down on deceptive drug advertising, targeting major pharma and telehealth firms. Read more here.

From loans to hemp to smoke-shop opioids, KC businessman pushes legal limits

He was convicted of selling marijuana, sued for his CBD products and is linked to figures with checkered pasts. Now this cannabis mogul says he’s willing to go back to prison over controversial pills.
pharmaphorum

Flood of warning letters follows DTC ad clampdown

Novo Nordisk's letter refers to the same Oprah Winfrey show and its GLP-1 weight-loss drug Wegovy (semaglutide), while CSL ...
pharmaphorum

FDA's Makary explains 'overdue' pharma ads crackdown

FDA Commissioner Marty Makary has called direct-to-consumer (DTC) advertising of pharmaceuticals a "public health crisis" in ...

Hims & Hers Is in the FDA’s Crosshairs. It’s a Risk to the Stock.

The FDA’s commissioner hasn’t mentioned any other drugmaker or retailer by name in his campaign against prescription drug ads ...
Fierce Pharma

FDA's Marty Makary deems DTC drug advertising 'a public health crisis' in JAMA editorial

FDA Commissioner Marty Makary, M.D., took aim at drugmakers, online pharmacies and social media influencers in a new op-ed ...